TRV
New number, same skeptical vibe
BofA Securities raised its price target on Travelers Companies to $276 from $257, but didn’t exactly throw a parade: the firm kept an Underperform rating on the stock. Translation: the analyst got a little less grumpy, but not enough to switch from “meh” to “buy.”
Why the bar stayed high
The note leaned on Travelers’ first-quarter results, which came with plenty of shiny bits and a few speed bumps:
- Core return on equity hit 19.7%, which is the kind of number that makes insurers sit up straighter.
- Share buybacks totaled $1.99 billion, beating BofA’s estimate.
- Favorable development came in at $413 million, way ahead of the firm’s forecast.
But there were also some thorns in the rose bouquet. Net written premium growth was negative 1.7%, catastrophe losses landed at $761 million, and the expense ratio ran a touch hot at 29%.
The investor takeaway
For you, the big question is whether Travelers can keep flexing that high ROE while the top line and underwriting metrics wobble a bit. BofA’s target hike says the quarter was better than expected — but the Underperform tag says the stock still isn’t cheap enough, or clean enough, to get a full thumbs-up.
Big picture: this is one of those classic “good company, not necessarily great stock” situations. The numbers improved, the target moved, but Wall Street still wants more proof before it starts clapping.